# What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol

> **NCT04359420** · NA · COMPLETED · sponsor: **University of Manchester** · enrollment: 32298 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** BC-Predict
- **OTHER:** NHS Breast Screening Programme

## Key facts

- **NCT ID:** NCT04359420
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2021-12-28
- **Final completion:** 2022-06-30
- **Target enrollment:** 32298 (ACTUAL)
- **Last updated:** 2023-01-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04359420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04359420, "What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04359420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*